These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 14707786)

  • 1. Risk associated HIV-1 cross-clade resistance of whole peripheral blood mononuclear cells from exposed uninfected individuals with wild-type CCR5.
    John R; Arango-Jaramillo S; Finny GJ; Schwartz DH
    J Acquir Immune Defic Syndr; 2004 Jan; 35(1):1-8. PubMed ID: 14707786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection against human immunodeficiency virus type 1 infection in persons with repeated exposure: evidence for T cell immunity in the absence of inherited CCR5 coreceptor defects.
    Goh WC; Markee J; Akridge RE; Meldorf M; Musey L; Karchmer T; Krone M; Collier A; Corey L; Emerman M; McElrath MJ
    J Infect Dis; 1999 Mar; 179(3):548-57. PubMed ID: 9952360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced CD4 T cell activation and in vitro susceptibility to HIV-1 infection in exposed uninfected Central Africans.
    Bégaud E; Chartier L; Marechal V; Ipero J; Léal J; Versmisse P; Breton G; Fontanet A; Capoulade-Metay C; Fleury H; Barré-Sinoussi F; Scott-Algara D; Pancino G
    Retrovirology; 2006 Jun; 3():35. PubMed ID: 16792805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial resistance to infection by R5X4 primary HIV type 1 isolates in an exposed-uninfected individual homozygous for CCR5 32-base pair deletion.
    Xiao L; Weiss SH; Qari SH; Rudolph D; Zhao C; Denny TN; Hodge T; Lal RB
    AIDS Res Hum Retroviruses; 1999 Sep; 15(13):1201-8. PubMed ID: 10480633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of CCR5-Delta32 deletion in human immunodeficiency virus type 1 (HIV-1) in healthy blood donors, HIV-1-exposed seronegative and HIV-1-seropositive individuals of southern Brazilian population.
    Reiche EM; Ehara Watanabe MA; Bonametti AM; Morimoto HK; Akira Morimoto A; Wiechmann SL; Matsuo T; Carvalho De Oliveira J; Vissoci Reiche F
    Int J Mol Med; 2008 Nov; 22(5):669-75. PubMed ID: 18949389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlates of resistance to HIV-1 infection in homosexual men with high-risk sexual behaviour.
    Koning FA; Jansen CA; Dekker J; Kaslow RA; Dukers N; van Baarle D; Prins M; Schuitemaker H
    AIDS; 2004 May; 18(8):1117-26. PubMed ID: 15166527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-cytotoxic inhibition of HIV-1 infection by unstimulated CD8+ T lymphocytes from HIV-exposed-uninfected individuals.
    Furci L; Lopalco L; Loverro P; Sinnone M; Tambussi G; Lazzarin A; Lusso P
    AIDS; 2002 May; 16(7):1003-8. PubMed ID: 11953466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms in the CCR5 coding and noncoding regions among HIV type 1-exposed, persistently seronegative female sex-workers from Thailand.
    Yang C; Li M; Limpakarnjanarat K; Young NL; Hodge T; Butera ST; McNicholl JM; Mastro TD; Lal RB
    AIDS Res Hum Retroviruses; 2003 Aug; 19(8):661-5. PubMed ID: 13678468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spontaneous and antigen-induced chemokine production in exposed but uninfected partners of HIV type 1-infected individuals in North India.
    Suresh P; Wanchu A; Bhatnagar A; Sachdeva RK; Sharma M
    AIDS Res Hum Retroviruses; 2007 Feb; 23(2):261-8. PubMed ID: 17331032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restriction of HIV type 1 infection in macrophages heterozygous for a deletion in the CC-chemokine receptor 5 gene.
    Ometto L; Zanchetta M; Cabrelle A; Esposito G; Mainardi M; Chieco-Bianchi L; De Rossi A
    AIDS Res Hum Retroviruses; 1999 Nov; 15(16):1441-52. PubMed ID: 10555107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-specific CD8 T-cell activity in uninfected injection drug users is associated with maintenance of seronegativity.
    Makedonas G; Bruneau J; Lin H; Sékaly RP; Lamothe F; Bernard NF
    AIDS; 2002 Aug; 16(12):1595-602. PubMed ID: 12172080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-specific cytotoxic T lymphocytes, HLA-A11, and chemokine-related factors may act synergistically to determine HIV resistance in CCR5 delta32-negative female sex workers in Chiang Rai, northern Thailand.
    Sriwanthana B; Hodge T; Mastro TD; Dezzutti CS; Bond K; Stephens HA; Kostrikis LG; Limpakarnjanarat K; Young NL; Qari SH; Lal RB; Chandanayingyong D; McNicholl JM
    AIDS Res Hum Retroviruses; 2001 May; 17(8):719-34. PubMed ID: 11429112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4 cell and CD8 cell-mediated resistance to HIV-1 infection in exposed uninfected intravascular drug users in Vietnam.
    Truong LX; Luong TT; Scott-Algara D; Versmisse P; David A; Perez-Bercoff D; Nguyen NV; Tran HK; Cao CT; Fontanet A; Follézou JY; Theodorou I; Barré-Sinoussi F; Pancino G
    AIDS; 2003 Jul; 17(10):1425-34. PubMed ID: 12824779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCR5-reactive antibodies in seronegative partners of HIV-seropositive individuals down-modulate surface CCR5 in vivo and neutralize the infectivity of R5 strains of HIV-1 In vitro.
    Lopalco L; Barassi C; Pastori C; Longhi R; Burastero SE; Tambussi G; Mazzotta F; Lazzarin A; Clerici M; Siccardi AG
    J Immunol; 2000 Mar; 164(6):3426-33. PubMed ID: 10706739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined effect of CCR5-Delta32 heterozygosity and the CCR5 promoter polymorphism -2459 A/G on CCR5 expression and resistance to human immunodeficiency virus type 1 transmission.
    Hladik F; Liu H; Speelmon E; Livingston-Rosanoff D; Wilson S; Sakchalathorn P; Hwangbo Y; Greene B; Zhu T; McElrath MJ
    J Virol; 2005 Sep; 79(18):11677-84. PubMed ID: 16140745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of infection in HIV-exposed individuals is associated with a strong CD8(+) cell noncytotoxic anti-HIV response.
    Stranford SA; Skurnick J; Louria D; Osmond D; Chang SY; Sninsky J; Ferrari G; Weinhold K; Lindquist C; Levy JA
    Proc Natl Acad Sci U S A; 1999 Feb; 96(3):1030-5. PubMed ID: 9927688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1-resistance phenotype conferred by combination of two separate inherited mutations of CCR5 gene.
    Quillent C; Oberlin E; Braun J; Rousset D; Gonzalez-Canali G; Métais P; Montagnier L; Virelizier JL; Arenzana-Seisdedos F; Beretta A
    Lancet; 1998 Jan; 351(9095):14-8. PubMed ID: 9433423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the CCR5 delta 32 allele in resistance to HIV-1 infection in west Africa.
    Kokkotou E; Philippon V; Guèye-Ndiaye A; Mboup S; Wang WK; Essex M; Kanki P
    J Hum Virol; 1998; 1(7):469-74. PubMed ID: 10195268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of systemic HIV-1-specific cellular immune responses by oral exposure in the uninfected partner of discordant couples.
    Pérez CL; Hasselrot K; Bratt G; Broliden K; Karlsson AC
    AIDS; 2010 Apr; 24(7):969-74. PubMed ID: 20397304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased susceptibility of peripheral blood mononuclear cells from individuals heterozygous for a mutant CCR5 allele to HIV infection.
    Kim A; Pettoello-Mantovani M; Goldstein H
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Oct; 19(2):145-9. PubMed ID: 9768623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.